Lung Cancer Center

  • News
New Lung Cancer Rx Targets Common Mutation
The US Food and Drug Administration (FDA) has approved a new lung cancer treatment that targets a common tumor mutation.
FDA OKs Targeted Lung Cancer Rx
The US Food and Drug Administration (FDA) has approved a targeted drug for a type of non-small cell lung cancer.
A New Treatment for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has approved a new treatment for non-small cell lung cancer (NSCLC).
A Drop in Lung Cancer Deaths
Deaths from the most common type of lung cancer have decreased rapidly in recent years. Researchers are saying new treatments are behind this good news.
Heated Tobacco Devices: Not a Safe Option
New heated tobacco devices are not a safe alternative to smoking traditional cigarettes or using electronic cigarettes, according to a new study.
FDA Approved Treatment Option - Non Small Cell Lung Cancer
An Approved Treatment Option For Previously Treated Advanced NSCLC. Learn More.
Lung Cancer Rx Receives FDA Approval
A lung cancer drug has received regular approval from the US Food and Drug Administration (FDA).
Approved: First Biosimilar Rx for Cancer
The US Food and Drug Administration (FDA) has approved the United States' first biosimilar drug to treat cancer.
Vitamin B and Lung Cancer: A Possible Link
Your high-dose B vitamin supplement may be raising your risk of lung cancer, a new study found.
Cancer Rx Combo Gets Green Light
The US Food and Drug Administration (FDA) has approved two new cancer treatments.
No Such Thing as a Safe Cigarette
Despite their marketing as a "healthier" option, so-called "light" filtered cigarettes may actually be causing more cases of a certain type of lung cancer, a new study found.
Lung Cancer Gets New Treatment
The US Food and Drug Administration (FDA) has approved a new medication to treat non-small cell lung cancer.
Tecentriq Gets a New Job
The US Food and Drug Administration has approved Tecentriq (atezolizumab) to treat advanced lung cancer.
Plus One for Lung Cancer Surgery
Surgery for patients with late-stage, non-small cell lung cancer (NSCLC) may increase survival, but many patients aren't having the procedure, a new study found.
Good News for Older Patients with Lung Cancer
Post-surgery survival rates for older patients with lung cancer may be improving, a new study found.
A New Job for Gilotrif
The US Food and Drug Administration has approved Gilotrif (afatinib) to treat squamous cell lung cancer.
A New Job for Xalkori
The US Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat patients with advanced non-small cell lung cancer (NSCLC) who have tumors with an ROS-1 gene alteration.
Is a PET Scan the Right Option for You?
For cancer survivors, vigilance is a key part of remaining cancer free. But new evidence suggests one cancer detection tool is being overused — and that isn’t helping anyone.
Melanoma Rx May Treat Lung Cancer, Too
Turns out a melanoma medication could also help patients with a different type of cancer.
New Guidelines for Smokers' Health Care
Smoking has been tied to numerous health issues. Now an expert panel has made recommendations for doctors who care for adults and pregnant women who smoke.
More